bearish
Beijing Airdoc Technology (2251.HK) - Not Optimistic About Turning Loss into Profit
283 Views21 Jun 2022 08:42
Without entering NRDL and public hospital markets, Airdoc’s products are hard to generate good performance due to high pricing but limited value. We are not optimistic Airdoc can turn loss into profit
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Beijing Airdoc Technology (2251.HK) - Not Optimistic About Turning Loss into Profit21 Jun 2022
- Pre-IPO Beijing Yuanxin Technology Group - Conservative About the Outlook17 Jun 2022
- Pre IPO Shukun Technology - Obvious Strength in Technology/Products but Commercialization Is the Key10 Jun 2022
- Beijing Airdoc Technology (2251.HK) - Here Are the Concerns10 Nov 2021
x